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cast doubts over the relative potency of these fluids in
several intensive care studies.4
When administering crystalloid as a bolus, clinicians must
continue the infusion at a lower step-down rate to main-
tain the plasma volume expansion that has just been
achieved (Fig. 1b). If not, the bolus infusion needs to
be repeated much more frequently than with a colloid,
since the latter lacks a redistribution phase and better
remains in the circulation.
Clinicians apparently handle this issue by accepting a
lower overall CI and giving bolus infusions more fre-
quently, which was the also case in the László et al.’s
study.1 However, their bolus infusions were administered
over a maximum of 15 min, which somewhat reduces the
distribution effect. A shorter infusion time, which is more
common, aggravates the problems associated with the
redistribution phase.
I give those who advocate crystalloids the possibility that
I am wrong in my scepticism. When urinary excretion is
very prompt, as in well hydrated conscious volunteers, the
infusion of a small amount of fluid does not always hydrate
the interstitial fluid space because excretion may occur
faster than the distribution.5 This is unlikely during ongo-
ing anaesthesia and surgery because urinary excretion is
strongly inhibited in that setting (90%).2 Moreover, the
results of László et al. indicate that their infusions were
subject to distribution in the way I suspect.
My kinetic considerations are not unique for infusion fluids
but pertain to all drugs with exponential distribution and
elimination. Hence, a crystalloid fluid should be continued
at a lower rate after a bolus infusion to achieve a stable
plasma volume expansion profile similar to that of a colloid.
Such a step-down is quite possible to perform, but never
practiced as far as I know. This is the rationale behind my
opinion that crystalloid fluids should be a second-choice for
goal-directed therapy during surgery.
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Editor,
We would like to thank Hahn1 for his comments
concerning our recently published trial on the effects
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Plasma volume expansion following three boluses of Ringer’s solution
infused with an interval of 40 min (a). The expansion resulting from the
first bolus is maintained with a gradual step-down infusion (b).
Computer simulation-based kinetic data from infusions of larger
amounts of fluid during thyroid surgery.3
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of goal-directed fluid therapy on microcirculation during
free flap surgery.2 We assume that most clinicians are
using crystalloids, while some, like Dr Hahn, prefer
colloids for their better volume : replacement ratio.
Basically, both crystalloids and colloids are suitable for
fluid resuscitation. According to Starling’s ‘3-compart-
ment model’, crystalloids are distributed in the extracel-
lular space, while colloids should remain intravascularly
due to their large molecular weight. However, clinical
trials seem to disprove this principle as we do not see this
large difference in the required volume of crystalloids
versus colloids to stabilise patients. Published data have
shown a strong association between acute kidney injury,
an increased use of renal replacement therapy and the use
of hydroxyethyl starch solution, which was also accompa-
nied with unfavourable patient outcome.3–5 However, in
these trials, the ratios of the administered volume of
crystalloids and colloids were completely different to
what should have been expected according to the Starling
principle. Theoretically, colloids have better volume
expansion effects, therefore they restore the circulating
blood volume and hence DO2 faster than crystalloids do.
A fluid challenge study shows that fluid responsiveness is
time-dependent and that the issue of optimal timing
needs to be addressed. Roger et al.6 aimed to evaluate
whether echocardiographic assessment of the response
to fluid challenge could affect the results by crystalloid
solutions. In this study, 51.3% of initial responders had
a persistent response to fluid 30 min after the beginning
of fluid infusion and only 41.3% had a transient response.5
However, fluid therapy, a main component of resuscitation,
may cause substantial endothelial injury.7 Preclinical stud-
ies show that fluid resuscitation degrades the endothelial
glycocalyx structure. The volume of intravenous fluids
during resuscitation is associated with the degree of gly-
cocalyx degradation. These findings suggest a potential
mechanism which may induce iatrogenic endothelial in-
jury.
In our moderate bleeding-resuscitation animal model,
the volume: replacement ratio for crystalloids and
colloids followed similar patterns as predicted by
Starling’s principle, and the glycocalyx remained
intact.7
Our study’s main finding is that when fluid management
is guided by detailed haemodynamic assessment, more
crystalloid than colloid is needed to maintain haemody-
namic stability. We did not find any difference between
the effects of crystalloids and colloids on the microcircu-
lation. Crystalloids actually have a worse volume : repla-
cement ratio than colloids, therefore complex monitoring
is essential for decision-making. Our results raise a point
that personalised therapy may be superior to guidelines/
bundles- driven management, which assumes the ‘one
size fits all’ paradigm, and leaves the question on the
crystalloid-colloid debate open.8
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Editor,
We read with great interest the recently published
article by Sivashanmugam et al.1 With regard to a lower
incidence of hemidiaphragmatic paresis, the costocla-
vicular brachial plexus block seems to be a promising
alternative to the supraclavicular brachial plexus block.
We appreciate the authors’ great work, but we have
several concerns.
First, patients with impaired pulmonary function (i.e.
obstructive or restrictive pulmonary disease) should have
been excluded from the study. In these patients, hemi-
diaphragmatic paralysis may result in severe conse-
quences. This was not mentioned among the
exclusion criteria.
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